ConforMIS Inc (CFMS) Misses Q3 EPS by 2c

ConforMIS Inc (NASDAQ: CFMS) reported Q3 EPS of ($0.13), $0.02 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $17.3 million versus the consensus estimate of $17.8 million.

"The third quarter, as expected, was challenging for us given the Aetna insurance coverage denials. I am pleased with our OUS performance improvement,” said Mark Augusti, President and Chief Executive Officer of Conformis, Inc. “Also, in the third quarter we had two very significant positive events occur. The first being the execution of the Stryker transaction for patient specific instrumentation as announced earlier this month. The second being the successful limited launch of our new Identity total knee system which has received excellent physician feedback.”

For earnings history and earnings-related data on ConforMIS Inc (CFMS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c